Integra LifeSciences IART Other income, net (Note 6)
Other income, net (Note 6) at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's other income, net (note 6).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's other income, net (note 6)?
- Integra LifeSciences (IART) reported other income, net (note 6) of $4.48M in Q1 2026.
- How has Integra LifeSciences's other income, net (note 6) changed year-over-year?
- Integra LifeSciences's other income, net (note 6) increased by 3211.1% year-over-year, from -$144K to $4.48M.
- What is the long-term trend for Integra LifeSciences's other income, net (note 6)?
- Over 3 years (2021 to 2024), Integra LifeSciences's other income, net (note 6) has grown at a -41.1% compound annual growth rate (CAGR), from $19.31M to $3.94M.
- What does other income, net (note 6) mean?
- This captures miscellaneous financial items that fall outside the scope of core operating activities, such as foreign exchange gains or losses, minor investment income, or non-recurring legal settlements. It serves as a catch-all for peripheral financial events that do not stem from the primary business operations. Investors monitor this to isolate core earnings from transient or incidental financial fluctuations.